Jill Henrich Atara Biotherapeutics, Inc. (ATRA) insider trading activity

Jill Henrich is EVP, Chief Regulatory Officer of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 18,679 shares of ATRA, which is worth approximately $115,062. The most recent transaction as insider was on Mar 03, 2025, when has been sold 1,059 shares (Common Stock) at a price of $7.0 per share, resulting in proceeds of $7,413. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.7K

3.61% 3M change

96.63% 12M change

Total Value Held $115,062

Jill Henrich Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 03 2025	SELL Open market or private sale	$7,413 $7.0 p/Share	1,059 Reduced 5.37%	18,679 Common Stock
Nov 18 2024	SELL Open market or private sale	$11,200 $11.2 p/Share	1,000 Reduced 4.91%	19,378 Common Stock
Aug 16 2024	SELL Open market or private sale	$6,384 $6.63 p/Share	963 Reduced 4.51%	20,378 Common Stock
May 16 2024	SELL Open market or private sale	$15,965 $0.62 p/Share	25,750 Reduced 4.64%	529,251 Common Stock
Mar 04 2024	SELL Open market or private sale	$2,792 $0.72 p/Share	3,879 Reduced 0.69%	555,001 Common Stock
Jan 08 2024	BUY Grant, award, or other acquisition	-	450,000 Added 44.6%	558,880 Common Stock
Nov 16 2023	SELL Open market or private sale	$1,274 $0.39 p/Share	3,267 Reduced 3.03%	104,424 Common Stock
Aug 16 2023	SELL Open market or private sale	$5,520 $1.65 p/Share	3,346 Reduced 3.01%	107,691 Common Stock

Jill Henrich

EVP, Chief Regulatory Officer

Thousand Oaks, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRA shares.

Notify only if

Value

Insider Trading

Get notified when an Atara Biotherapeutics, Inc. insider buys or sells ATRA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Atara Biotherapeutics, Inc.

Track Activities on ATRA

Account